In patients with Parkinson’s disease (PD), the localization of AQP4 in the end-feet of astrocytes is reduced (AQP4 depolarization), manifested as metabolic disorders in cerebrospinal fluid reflux and neurotransmitter clearance related to the impaired glymphatic system [113]. Here, AQP4 is linked to Other metabolic disease.